IL100274A - Pharmaceutical compositions containing functionalized vinyl azole derivatives novel functionalized vinyl azole derivatives and processes for the preparation of same - Google Patents
Pharmaceutical compositions containing functionalized vinyl azole derivatives novel functionalized vinyl azole derivatives and processes for the preparation of sameInfo
- Publication number
- IL100274A IL100274A IL10027491A IL10027491A IL100274A IL 100274 A IL100274 A IL 100274A IL 10027491 A IL10027491 A IL 10027491A IL 10027491 A IL10027491 A IL 10027491A IL 100274 A IL100274 A IL 100274A
- Authority
- IL
- Israel
- Prior art keywords
- group
- formula
- atom
- radical
- pharmaceutical preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C07D233/61—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4039559A DE4039559A1 (de) | 1990-12-07 | 1990-12-07 | Funktionalisierte vinylazole, verfahren zu deren herstellung, pharmazeutische praeparate die diese vinylazole enthalten sowie deren verwendung zur herstellung von arzneimitteln |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL100274A0 IL100274A0 (en) | 1992-09-06 |
| IL100274A true IL100274A (en) | 1996-08-04 |
Family
ID=6420083
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL10027491A IL100274A (en) | 1990-12-07 | 1991-12-08 | Pharmaceutical compositions containing functionalized vinyl azole derivatives novel functionalized vinyl azole derivatives and processes for the preparation of same |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5344834A (cs) |
| EP (1) | EP0550697A1 (cs) |
| JP (1) | JPH06503818A (cs) |
| KR (1) | KR930703263A (cs) |
| CN (1) | CN1064863A (cs) |
| AU (1) | AU660296B2 (cs) |
| CA (1) | CA2097824C (cs) |
| CS (1) | CS369691A3 (cs) |
| DE (1) | DE4039559A1 (cs) |
| FI (1) | FI932572A7 (cs) |
| HU (1) | HUT64036A (cs) |
| IE (1) | IE914259A1 (cs) |
| IL (1) | IL100274A (cs) |
| NO (1) | NO304428B1 (cs) |
| PT (1) | PT99714B (cs) |
| WO (1) | WO1992010482A1 (cs) |
| ZA (1) | ZA919662B (cs) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5418250A (en) * | 1989-06-14 | 1995-05-23 | Smithkline Beecham Corporation | Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists |
| GB2273704B (en) * | 1992-12-16 | 1997-01-22 | Orion Yhtymae Oy | Triazolyl diaryl selective aromatase inhibiting compounds |
| US5395847A (en) * | 1993-12-02 | 1995-03-07 | Smithkline Beecham Corporation | Imidazolyl-alkenoic acids |
| EP0943333A1 (de) * | 1998-03-18 | 1999-09-22 | S.W. Patentverwertungs GmbH | Medikament zur Prophylaxe und/oder Behandlung des Mammakarzinoms enthaltend einen Hemmer der Bildung von Oestrogenen |
| US20020086856A1 (en) | 1998-03-18 | 2002-07-04 | Alfred Schmidt | Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor |
| CN100358866C (zh) * | 2004-04-08 | 2008-01-02 | 上海交通大学 | 含对强碱不稳定取代基的n-乙烯基取代吡咯的制备方法 |
| JP6470984B2 (ja) * | 2015-01-27 | 2019-02-13 | 学校法人東日本学園 | アロマターゼ阻害剤及びこれを含む医薬 |
| CN105732977B (zh) * | 2016-01-30 | 2018-03-02 | 宝鸡文理学院 | 一种可溶性聚苯并二噻唑‑酰胺荧光聚合物及其制备方法和应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1580535A (en) * | 1976-08-27 | 1980-12-03 | Ici Ltd | Substituted ketones and their use as herbicides |
| EP0003884A3 (en) * | 1978-02-23 | 1979-09-19 | Imperial Chemical Industries Plc | Alpha-beta unsaturated ketone derivatives useful as herbicides |
| DE2826760A1 (de) * | 1978-06-19 | 1980-01-03 | Hoechst Ag | Derivate des 1,2,4-triazols |
| JPS62149666A (ja) * | 1985-12-25 | 1987-07-03 | Shionogi & Co Ltd | Ｎ−ビニルアゾ−ル類 |
| US4749713A (en) * | 1986-03-07 | 1988-06-07 | Ciba-Geigy Corporation | Alpha-heterocycle substituted tolunitriles |
| GB8716650D0 (en) * | 1987-07-15 | 1987-08-19 | Ici Plc | Use of olefinic compounds |
-
1990
- 1990-12-07 DE DE4039559A patent/DE4039559A1/de not_active Withdrawn
-
1991
- 1991-12-05 CS CS913696A patent/CS369691A3/cs unknown
- 1991-12-06 PT PT99714A patent/PT99714B/pt not_active IP Right Cessation
- 1991-12-06 CN CN91112779A patent/CN1064863A/zh active Pending
- 1991-12-06 ZA ZA919662A patent/ZA919662B/xx unknown
- 1991-12-08 IL IL10027491A patent/IL100274A/en not_active IP Right Cessation
- 1991-12-09 HU HU931657A patent/HUT64036A/hu unknown
- 1991-12-09 AU AU90454/91A patent/AU660296B2/en not_active Ceased
- 1991-12-09 EP EP19920900266 patent/EP0550697A1/de not_active Withdrawn
- 1991-12-09 CA CA002097824A patent/CA2097824C/en not_active Expired - Fee Related
- 1991-12-09 JP JP4500378A patent/JPH06503818A/ja active Pending
- 1991-12-09 KR KR1019930701698A patent/KR930703263A/ko not_active Ceased
- 1991-12-09 WO PCT/EP1991/002359 patent/WO1992010482A1/de not_active Ceased
- 1991-12-09 IE IE425991A patent/IE914259A1/en unknown
- 1991-12-09 US US07/802,639 patent/US5344834A/en not_active Expired - Fee Related
-
1993
- 1993-06-04 FI FI932572A patent/FI932572A7/fi unknown
- 1993-06-04 NO NO932044A patent/NO304428B1/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO304428B1 (no) | 1998-12-14 |
| CN1064863A (zh) | 1992-09-30 |
| EP0550697A1 (de) | 1993-07-14 |
| HUT64036A (en) | 1993-11-29 |
| DE4039559A1 (de) | 1992-06-11 |
| CA2097824C (en) | 2003-04-08 |
| IL100274A0 (en) | 1992-09-06 |
| PT99714B (pt) | 1999-05-31 |
| ZA919662B (en) | 1992-09-30 |
| NO932044L (no) | 1993-06-04 |
| JPH06503818A (ja) | 1994-04-28 |
| IE914259A1 (en) | 1992-06-17 |
| AU660296B2 (en) | 1995-06-22 |
| AU9045491A (en) | 1992-07-08 |
| KR930703263A (ko) | 1993-11-29 |
| NO932044D0 (no) | 1993-06-04 |
| HU9301657D0 (en) | 1993-09-28 |
| CA2097824A1 (en) | 1992-06-08 |
| CS369691A3 (en) | 1992-06-17 |
| WO1992010482A1 (de) | 1992-06-25 |
| FI932572A0 (fi) | 1993-06-04 |
| FI932572A7 (fi) | 1993-06-04 |
| PT99714A (pt) | 1992-10-30 |
| US5344834A (en) | 1994-09-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK170202B1 (da) | 1,5-diaryl-3-substituerede pyrazolforbindelser, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende forbindelserne | |
| US4495195A (en) | Xanthine oxidase inhibiting 3(5)-phenyl-substituted-5(3)-pyrazole-carboxylic acid derivatives, compositions, and methods of use | |
| US4402968A (en) | Antifungal benzofuranyl imidazole compounds | |
| JP2000204070A (ja) | 新規なアリールエテニレン誘導体及びその製法 | |
| US4194003A (en) | New pyrrole derivatives, process for their preparation and therapeutic applications thereof | |
| HU211567A9 (en) | Piperazine derivative | |
| HU193529B (en) | Process for producing n-imidazolyl-derivatives of bicyclic compounds | |
| EP0252476A2 (en) | Trans-6-[2-(N-heteroaryl-3,5-disubstituted) pyrazol-4-yl)-ethyl]- or ethenyl] tetrahydro-4-hydroxypyran-2-one-derivatives a process for their preparation and the use thereof | |
| US5344834A (en) | Functionalized vinyl azoles and methods of use | |
| US4581369A (en) | Imidazole derivatives | |
| HU201015B (en) | Process for producing pyridine derivatives | |
| US5965600A (en) | 3-(bis-substituted phenylmethylene) oxindole derivatives | |
| HU203722B (en) | Process for producing substituted hydroxyamines and pharmaceutical compositions containing them | |
| US4496735A (en) | Certain pyridyloxy-or-thio-phenyl propenoic acid derivatives | |
| US5411982A (en) | Cycloalkylene azoles, and their use as aromatase inhibitors | |
| EP0096890B1 (en) | Oxazoleacetic acid derivatives, process for their production and compositions containing said derivatives | |
| US5962686A (en) | N-benzylazolium derivatives | |
| HU211664A9 (en) | Saccharin derivative proteolytic enzime inhibitors | |
| KR910009200B1 (ko) | 아졸계 디옥솔란 유도체의 제조방법 | |
| US5013734A (en) | Novel esters of phenylalkanoic acid | |
| IE921936A1 (en) | Bicyclic-substituted vinylimidazoles, -triazoles and¹-tetrazoles | |
| US3952007A (en) | Processes for preparing 5-nitro-1-methyl-2-(2-dialkylaminovinyl)-imidazole and 5-nitro-1-methyl-2-imidazolyl carboxaldehyde | |
| CA2074846A1 (en) | "2-(imidazol-1-yl)-2-benzylethylidene-aminoxyalkanoic acid derivatives" | |
| US4293553A (en) | 1-Phthalazone derivatives, and use thereof | |
| US4665080A (en) | Imidazolyl compounds and their use as medicaments |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |